Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01342133 · ClinicalTrials.gov registry record
Sweat Duct Imaging in Mother/Newborn Dyads
A clinical trial of X-Linked Hypohidrotic Ectodermal Dysplasia, sponsored by Edimer Pharmaceuticals.
- Completed
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT01342133 is a study of X-Linked Hypohidrotic Ectodermal Dysplasia that has completed, run by Edimer Pharmaceuticals. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01342133, a study of X-Linked Hypohidrotic Ectodermal Dysplasia, has completed, sponsored by Edimer Pharmaceuticals.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate sweat duct number on the plantar surface of newborn infants using a non-invasive confocal microscopy device.
Conditions Studied
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01342133
The ClinicalTrials.gov registry entry for NCT01342133 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edimer Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with X-Linked Hypohidrotic Ectodermal Dysplasia appearing as the primary indexed condition, and to 0 interventions.
NCT01342133 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT01342133 about?
NCT01342133 is a clinical study titled "Sweat Duct Imaging in Mother/Newborn Dyads". The purpose of this study is to evaluate sweat duct number on the plantar surface of newborn infants using a non-invasive confocal microscopy device.
What is the current status of trial NCT01342133?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2011-04. Estimated completion is 2011-07.
What conditions does trial NCT01342133 study?
This clinical trial studies the following conditions: X-Linked Hypohidrotic Ectodermal Dysplasia.
Who is sponsoring clinical trial NCT01342133?
This trial is sponsored by Edimer Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01342133 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.